Evidence map›Paper›PMID 24763686›Full record

ArticleStem cells translational medicine2014

Increased genomic integrity of an improved protein-based mouse induced pluripotent stem cell method compared with current viral-induced strategies.

Hansoo Park, Dohoon Kim, Chun-Hyung Kim, Ryan E Mills, Mi-Yoon Chang, Rebecca Cheryl Iskow, Sanghyeok Ko, Jung-Il Moon, Hyun Woo Choi, Paulo Sng Man Yoo and 7 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Stem cells translational medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Stem cells: the pursuit of genomic stability.International journal of molecular sciences · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Hansoo ParkDepartment of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Molecular Neurobiology Laboratory, McLean Hospital/Harvard Medical School, Belmont, Massachusetts, USA; Harvard Stem Cell Institute, Boston, Massachusetts, USA; Department of Animal Biotechnology, College of Animal Bioscience and Technology, Konkuk University, Seoul, Korea; Biotechnology Process Engineering Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon, Korea; Advanced Cell Technology, Marlborough, Massachusetts, USA.
Dohoon Kim
Chun-Hyung Kim
Ryan E Mills
Mi-Yoon Chang
Rebecca Cheryl Iskow
Sanghyeok Ko
Jung-Il Moon
Hyun Woo Choi
Paulo Sng Man Yoo
Jeong Tae Do
Min-Joon Han
Eun Gyo Lee
Joon Ki Jung
Chengsheng Zhang
Robert Lanza
Kwang-Soo Kim
Harvard University · USHarvard Stem Cell Institute · USBrigham and Women's Hospital · USKonkuk University · KRKorea Research Institute of Bioscience and Biotechnology · KRMcLean Hospital · USAdvanced Cell Technology (United States) · US

Funding

Protein-induced human iPS cells for personalized cell therapy of PDR01NS070577 · NINDS · MCLEAN HOSPITAL · PI KIM, KWANG-SOO, KORDOWER, JEFFREY H · 2010 to 2020
$4.9M
Patient-specific and universal donor blood cell from protein-induced iPS cellsRC4HL106627 · NHLBI · MCLEAN HOSPITAL · PI KIM, KWANG-SOO, LANZA, ROBERT P · 2010 to 2010
$1.9M
Functional Roles of Nurr1 for Midbrain Dopamine Neurons in Health and DiseaseR01NS084869 · NINDS · MCLEAN HOSPITAL · PI KIM, KWANG-SOO · 2014 to 2018
$1.7M
Discovery and analysis of structural variation in whole genome sequencesR01HG007068 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MILLS, RYAN E · 2013 to 2016
$1.5M
Optimal Generation and Characterization of iPS Cell Lines from Healthy and ADHD SR33MH087903 · NIMH · MCLEAN HOSPITAL · PI KIM, KWANG-SOO · 2011 to 2012
$784k
Optimal Generation and Characterization of iPS Cell Lines from Healthy and ADHD SR21MH087903 · NIMH · MCLEAN HOSPITAL · PI KIM, KWANG-SOO · 2009 to 2010
$627k
NHGRI NIH HHS R01 HG007068NHLBI NIH HHS HL106627NHLBI NIH HHS RC4 HL106627NIMH NIH HHS MH087903NIMH NIH HHS R21 MH087903NIMH NIH HHS R33 MH087903NINDS NIH HHS NS070577NINDS NIH HHS R01 NS070577NINDS NIH HHS R01 NS084869
6 · The paper itself

Abstract

It has recently been shown that genomic integrity (with respect to copy number variants [CNVs]) is compromised in human induced pluripotent stem cells (iPSCs) generated by viral-based ectopic expression of specific transcription factors (e.g., Oct4, Sox2, Klf4, and c-Myc). However, it is unclear how different methods for iPSC generation compare with one another with respect to CNV formation. Because array-based methods remain the gold standard for detecting unbalanced structural variants (i.e., CNVs), we have used this approach to comprehensively identify CNVs in iPSC as a proxy for determining whether our modified protein-based method minimizes genomic instability compared with retro- and lentiviral methods. In this study, we established an improved method for protein reprogramming by using partially purified reprogramming proteins, resulting in more efficient generation of iPSCs from C57/BL6J mouse hepatocytes than using protein extracts. We also developed a robust and unbiased 1 M custom array CGH platform to identify novel CNVs and previously described hot spots for CNV formation, allowing us to detect CNVs down to the size of 1.9 kb. The genomic integrity of these protein-based mouse iPSCs (p-miPSCs) was compared with miPSCs developed from viral-based strategies (i.e., retroviral: retro-miPSCs or lentiviral: lenti-miPSCs). We identified an increased CNV content in lenti-miPSCs and retro-miPSCs (29∼53 CNVs) compared with p-miPSCs (9∼10 CNVs), indicating that our improved protein-based reprogramming method maintains genomic integrity better than current viral reprogramming methods. Thus, our study, for the first time to our knowledge, demonstrates that reprogramming methods significantly influence the genomic integrity of resulting iPSCs.

Indexed as

Genomic InstabilityInduced Pluripotent Stem CellsLentivirusTranscription FactorsTransduction, GeneticAnimalsHEK293 CellsHumansKruppel-Like Factor 4MiceKLF4 protein, humanKlf4 protein, mouseKruppel-Like Factor 4Transcription FactorsCopy number variantGenomic integrityInduced pluripotent stem cellProtein-based iPSCReprogramming method

Identifiers

PMID24763686
PMCPMC4006484
OpenAlexW1979315586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.